average weight loss for tirzepatide How Much Can You Lose with Zepbound tirzepatide clinical trial weight loss

The study was registered at ClinicalTrials.gov (NCT04560998)

This distinction matters in the GLP-1 market, as regulatory scrutiny, quality controls, and allowable production practices vary significantly between the two models and, as of April 2026, the two tiers face meaningfully different enforcement exposure

If youre interested to learn more, we have a guide about GLP-1 receptor agonists

"Why should GLP-1s be different?" Woodard, who is head of human resources for a large company, says her new perspective helped her successfully advocate to include coverage of GLP-1s in her employer's health insurance plan, which she says is not the norm